BCM
XBIT icon

Bridgeway Capital Management’s XBiotech XBIT Stock Holding History

Bridgeway Capital Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$231K Buy
98,447
+8,900
+10% +$21.5K ﹤0.01% 1000
2025
Q4 		$214K Buy
89,547
+30,000
+50% +$74K ﹤0.01% 1005
2025
Q3 		$158K Buy
59,547
+221
+0.4% +$654 ﹤0.01% 1050
2025
Q2 		$176K Sell
59,326
-63,706
-52% -$185K ﹤0.01% 985
2025
Q1 		$399K Sell
123,032
-21,598
-15% -$74.5K 0.01% 783
2024
Q4 		$571K Sell
144,630
-2,962
-2% -$20.2K 0.01% 783
2024
Q3 		$1.14M Sell
147,592
-6,586
-4% -$43.3K 0.02% 648
2024
Q2 		$792K Buy
154,178
+4,860
+3% +$37.5K 0.02% 749
2024
Q1 		$1.21M Buy
149,318
+4,725
+3% +$27.1K 0.02% 691
2023
Q4 		$578K Buy
144,593
+5,352
+4% +$21.3K 0.01% 903
2023
Q3 		$574K Buy
139,241
+12,565
+10% +$62.9K 0.01% 841
2023
Q2 		$752K Buy
126,676
+12,336
+11% +$55.7K 0.02% 798
2023
Q1 		$394K Sell
114,340
-9,060
-7% -$33.8K 0.01% 939
2022
Q4 		$433K Sell
123,400
-9,600
-7% -$32.7K 0.01% 915
2022
Q3 		$481K Buy
133,000
+102,500
+336% +$482K 0.01% 904
2022
Q2 		$172K Buy
+30,500
New +$205K ﹤0.01% 1124
2020
Q3 		– Sell
-22,300
Closed -$306K – 1366
2020
Q2 		$306K Buy
+22,300
New +$313K 0.01% 1032

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bridgeway Capital Management's XBIT Position: Q1 2026 in Review

Bridgeway Capital Management increased its XBiotech (XBIT) stake by 9.9% in Q1 2026, buying an estimated $21.5K and bringing the position to 98,447 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1000.

Bridgeway Capital Management first reported a position in XBIT in Q2 2020 and has held it in 17 quarters since. The position peaked at $1.21M in Q1 2024. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Bridgeway Capital Management held 98,447 shares of XBiotech worth $231K as of Q1 2026.
  • Bridgeway Capital Management bought 8,900 XBiotech shares in Q1 2026, an estimated $21.5K.
  • XBiotech made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1000 holding.
  • Bridgeway Capital Management first reported a position in XBiotech in Q2 2020 and has held it in 17 quarters since.
  • Bridgeway Capital Management's XBiotech position peaked at $1.21M in Q1 2024.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.